drugset / Trial / NCT03141476

Adequacy of Perioperative Cefuroxime Dosage According to the BMI

NCT03141476

Phase 4 Completed 60 enrolled University Medical Center Hamburg-Eppendorf
RandomizedParallel-groupOpen-labelPrevention

Summary

This study evaluates the dosage of perioperative cefuroxime for obese patients. Dosage was increased if the BMI was over 30kg/m\*m and as well over 50kg/m\*m. Drug levels were measured in blood and tissue.

Timeline

Start
2017-03-01
Primary completion
2017-11-12
Completion
2017-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefuroxime Small molecule 1.5 g
Subject Cefuroxime Small molecule 3 g
Subject Cefuroxime Small molecule 4.5 g

Indications